Tools that show surgeons where the tumour ends during the operation could cut the number of patients who need a second operation, but none has been properly tested at scale. A network would run those trials and pay on results.
A standing network of surgical centres running randomised, pragmatic trials of fluorescence-guided surgery agents, intraoperative specimen imaging, optical and mass-spectrometry margin probes and AI-based margin prediction, with positive-margin and re-operation rates as primary endpoints and payer contracts that reimburse devices on demonstrated margin reduction. Several agents and devices are approved or near approval, but adoption is slow because evidence is single-centre and payers are unconvinced. The network would also standardise pathology margin assessment, which varies enough to confound trials.
Shares Global cancer surgery: delivering safe, affordable, and timely cancer surgery, Intraoperative margin assessment in breast-conserving surgery, Optical & fluorescence imaging, Fluorescence-guided surgery.
Shares Global cancer surgery: delivering safe, affordable, and timely cancer surgery, A permanently funded international network for randomised cancer surgery trials, Surgery and radiotherapy cure most, get least, Prostate cancer.
Shares Global cancer surgery: delivering safe, affordable, and timely cancer surgery, Surgery and radiotherapy cure most, get least, HR-positive / HER2-negative breast cancer, Prostate cancer.
Shares Intraoperative margin assessment in breast-conserving surgery, Optical & fluorescence imaging, Fluorescence-guided surgery, HR-positive / HER2-negative breast cancer.
Shares Intraoperative margin assessment in breast-conserving surgery, Optical & fluorescence imaging, Fluorescence-guided surgery, HR-positive / HER2-negative breast cancer.
Shares Global cancer surgery: delivering safe, affordable, and timely cancer surgery, A permanently funded international network for randomised cancer surgery trials, Surgery and radiotherapy cure most, get least.
Shares Global cancer surgery: delivering safe, affordable, and timely cancer surgery, A permanently funded international network for randomised cancer surgery trials, Surgery and radiotherapy cure most, get least, Prostate cancer.
Shares Global cancer surgery: delivering safe, affordable, and timely cancer surgery, Fluorescence-guided surgery, Surgery and radiotherapy cure most, get least.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/